Teva's Cephalon buyout close to EU nod; Rival bidder out, Allos still in talks with Amag;

@FiercePharma: Already owing huge amounts to drugmakers, Spain shuts ERs, proposes physician pay cut - Reuters #pharma. Article |  Follow @FiercePharma

> Teva Pharmaceutical Industries ($TEVA) is on the verge of wining conditional EU approval for its buyout of U.S.-based Cephalon ($CEPH), sources tell Reuters. Report

> Allos Therapeutics ($ALTH) says it's still in talks to sell itself to Amag Pharmaceuticals ($AMAG) after a rival bidder pulled out. Item

> Wisconsin contract manufacturer Anteco Pharma is breaking ground on a $3.5 million addition to its facility in the first phase of a 5-year expansion plan. Article

> The contract manufacturing association has joined calls to cut the tax rate on repatriated foreign earnings. Story

> Aurobindo Pharma won final FDA approval for its version of the Pfizer ($PFE) CNS drug Neurontin. Report

> The U.S. Pharmacopeial Convention has teamed up with Russian regulators to help raise standards for drugs made in that country. Article

> Shaanxi Aoxing Pharmaceutical agreed to buy Shaanxi Weinan Huaren Pharmaceuticals and its portfolio of 86 drugs for $9.62 million. Item

> Young and middle-aged people with prehypertension have a much higher risk of stroke than those with normal blood pressure. Report

Biotech News

 @FierceBiotech: Roche spotlights PhI efficacy of Alzheimer's antibody. Article | Follow @FierceBiotech

 @ JohnCFierce: Glaxo R&D chief Slaoui outlines his formula for success. News | Follow @JohnCFierce

 @RyanMFierce: I saw twitter action on this fertility startup OvaScience a while ago, but @scottkirsner is first to write an article. Report | Follow @RyanMFierce

> Glaxo R&D chief Slaoui outlines his formula for success. Story

> Roche spotlights PhI efficacy of Alzheimer's antibody. Item 

> Biotech startup Cleave lands $42M A round for targeted cancer drugs. Article

Manufacturing News

> Counterfeits quantified. Story

> AZ ups emerging markets bet with $200M plant in China. Report 

> Sanofi's Viehbacher sees green lights ahead for Shantha. Article

> Kimberly-Clark program gives new life to cleanroom garb. Report

> Sen. Schumer asks FTC to probe gray market mark-ups in drug shortages. Story

> Teva, partners fined $20M in second propofol/Hep-C case. News

Biotech Research News

> Great minds collaborate on new RNAi approach to inflammation. Story

> Cloning tech used to create breakthrough stem cells for research. Article

> Diabetes science team finds a "negative regulator" for insulin secretion. Report

> Natural compound shows promise as a pathway to diabetes pill. Item

And Finally... Israeli doctors walked out en masse in a salary dispute, forcing hospitals to turn some patients away. Story

Suggested Articles

AbbVie and Allergan were already jumping through hoops for their merger before a new tax added hundreds of millions to the cost.

Avastin and Herceptin saw U.S. slowdown that's “not very pronounced” after bioisim launched, but Roche execs still warn of "a significant impact.…

Novo Nordisk, which recently completed a wastewater treatment plant for its massive U.S. API site, has made a gift of the $40 million facility.